My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

34.67 -0.13 (-0.37%)

Official Closing Price Updated: 5:00 PM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

48 49 Next >

The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight

December 12, 2024

From Hims & Hers

Via Business Wire

Hims & Hers Health Unusual Options Activity ↗

December 11, 2024

Via Benzinga

4 Stocks That Crushed Analyst Estimates by More Than Double

December 11, 2024

Hims & Hers, Alcoa, Vicor, and Stride crushed earnings with massive EPS beats. See what’s driving their growth and future potential.

Via MarketBeat

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 10, 2024

Via Benzinga

Where Hims & Hers Health Stands With Analysts ↗

December 02, 2024

Via Benzinga

Exploring growth characteristics of HIMS & HERS HEALTH INC (NYSE:HIMS). ↗

November 28, 2024

Should you consider HIMS & HERS HEALTH INC (NYSE:HIMS) for growth investing?

Via Chartmill

Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity ↗

November 27, 2024

Via Benzinga

Unpacking the Latest Options Trading Trends in Hims & Hers Health ↗

November 18, 2024

Via Benzinga

Amazon’s Healthcare Gamble: A New Era of Medical Disruption

December 10, 2024

Amazon's strategic healthcare expansion leverages technology and logistics for a potentially transformative impact on patient care and market dynamics.

Via MarketBeat

Topics Artificial Intelligence

10 Health Care Stocks Whale Activity In Today's Session ↗

December 05, 2024

Via Benzinga

2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick

December 05, 2024

Discover two telehealth stocks, Hims & Hers (HIMS) and Teladoc (TDOC), poised to benefit from Trump's FDA nominee, Dr. Marty Makary, a telemedicine advocate.

Via MarketBeat

Topics Government Lawsuit

The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market ↗

December 05, 2024

An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in obesity.

Via Investor's Business Daily

Price Over Earnings Overview: Hims & Hers Health ↗

November 18, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 04, 2024

Via Benzinga

Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category

December 03, 2024

From Hims & Hers

Via Business Wire

Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio? ↗

December 01, 2024

8 mid-cap stocks saw impressive gains last week. Archer, Scholar Rock, Arrowhead, Iris Energy, Hims & Hers, SoundHound, Joby Aviation, and Urban Outfitters all performed well.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 29, 2024

Via Benzinga

Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch

November 28, 2024

Here's why Eli Lilly, Pfizer, and AstraZeneca are biotech stocks worth considering, with strong pipelines and growth potential beyond vaccines.

Via MarketBeat

Topics Government

Why Hims & Hers Stock Jumped on Massive FDA News ↗

November 26, 2024

Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.

Via The Motley Fool

Technical Monday: A Fresh Look At The “Vanity” Trade ↗

November 25, 2024

Nu Skin is an American multi-level marketing company for personal care products and dietary supplements.

Via Talk Markets

Topics ETFs Stocks / Equities

What's Going On With Hims & Hers Health Stock Monday? ↗

November 25, 2024

Shares of Hims & Hers Health, Inc. (NYSE: HIMS) traded higher on Monday in response to President-elect Donald Trump's plans to nominate Marty Makary to lead the Food and Drug Administration (FDA)....

Via Benzinga

Topics Government

BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday ↗

November 25, 2024

Via Benzinga

Applied Digital And Hims & Hers Health Are Among Top 9 Mid-Cap Gainers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio? ↗

November 24, 2024

The top performers in the last week were Lemonade, Inc., Archer Aviation Inc., C3.ai, Inc., Oklo Inc., Applied Digital Corporation, Unity Software Inc., Nebius Group N.V., NuScale Power Corporation,...

Via Benzinga

Hims & Hers New Growth Category Is a Huge Surprise ↗

November 22, 2024

Is the food business the right business for Hims & Hers to be in?

Via The Motley Fool

Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys

November 21, 2024

From Hims & Hers

Via Business Wire

Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock? ↗

November 20, 2024

Via The Motley Fool

Guardant Health Stock Sees RS Rating Jump To 83 ↗

November 20, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83.

Via Investor's Business Daily

Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions

November 18, 2024

From Hims & Hers

Via Business Wire

Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 16 ↗

November 16, 2024

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Nov. 11-15, 2024.

Via Talk Markets

Hims & Hers Stock Is Down 30% This Week: Here's What Happened ↗

November 16, 2024

Hims & Hers has given back recent gains, but don't overlook the company's massive growth.

Via The Motley Fool

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

48 49 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.